Greater Glasgow and Clyde Medicines
Key to symbols The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP The medicine should only be used and prescribed by a specialist Indicates the preferred choice within a class or group of medicines
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
13. Skin

13.11. Skin cleansers, antiseptics, and preparations for promotion of wound healing

13.11.1. Alcohols and saline

Preferred List
INDUSTRIAL METHYLATED SPIRIT

Prescribing Notes:

Used for skin preparation prior to injection.

BNF Link

SODIUM CHLORIDE

Prescribing Notes:

Sterile sodium chloride 0.9% is often used as an irrigation fluid for wounds and ulcers.

BNF Link

Total Formulary
SURGICAL SPIRIT

13.11.2. Chlorhexidine salts

Preferred List
CHLORHEXIDINE GLUCONATE

Prescribing Notes:

Brands include: Hibiscrub®, Hydrex® and Unisept®. See individual preparation literature for appropriate uses and directions.

BNF Link

CHLORHEXIDINE AND CETRIMIDE (TISEPT) (solution)

Prescribing Notes:

Used for general skin disinfection and wound cleansing.

BNF Link

CHLORHEXIDINE AND CETRIMIDE (TRAVASEPT 100) (SOLUTION)

13.11.3. Cationic surfactants and soaps

For skin cleansing preparations that contain cetrimide, see section 13.11.2

13.11.4. Iodine

Preferred List
POVIDONE-IODINE

Prescribing Notes:

The following preparations are available for prescribing on the NHS in primary care:

  • Betadine® Dry Powder Spray

See individual preparation literature for appropriate uses and directions.

BNF Link

13.11.5. Phenolics

13.11.6. Oxidisers and dyes

Preferred List
HYDROGEN PEROXIDE BP (solution)

Prescribing Notes:

The 6% solution should be used for skin disinfection, particularly cleaning and deodorising of wounds and ulcers. For other topical antiinfective preparations containing hydrogen peroxide, see section 13.10.1.1.

BNF Link

POTASSIUM PERMANGANATE

Prescribing Notes:

  • Available as 0.1% topical solution, which should be diluted 1 in 10, and as Permitabs®, where 1 tablet dissolved in 4 litres of water provides a 0.01% topical solution. See BNF and product literature for further information.
  • In primary care, prescribers should be experienced in the treatment of dermatological conditions and the use of potassium permanganate. Prescriptions should be issued for named patients.
  • For further information on all safety aspects including storage, prescribing and administration in all care sectors, please refer to this guideline from the British Association of Dermatologists (April 2022).

BNF Link

Total Formulary
ZINC SULPHATE

13.11.7. Preparations for promotion of wound healing

Preferred List
SILVER SULFADIAZINE (FLAMAZINE)